Phase IIA trial of bupropion/trazodone for male hypoactive sexual desire disorder.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 20 Aug 2015
At a glance
- Drugs Bupropion/trazodone (Primary)
- Indications Decreased libido
- Focus Therapeutic Use
- Sponsors S1 Biopharma
- 20 Aug 2015 Results published in the Media Release.
- 19 Aug 2015 Status changed from not yet recruiting to active, no longer recruiting according to an S1 Biopharma media release.
- 03 Apr 2014 New trial record